Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$83.79 USD
-0.20 (-0.24%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $83.79 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $1.66 | 0.00% |
Earnings Summary
For their last quarter, Gilead Sciences (GILD) reported earnings of $2.01 per share, beating the Zacks Consensus Estimate of $1.61 per share. This reflects a positive earnings surprise of 24.84%. Look out for GILD's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of $1.66 per share, reflecting a year-over-year decrease of 27.51%.
Earnings History
Price & Consensus
Zacks News for GILD
AZN Stock Slips as Dato-DXd Cancer Study Misses Survival Goal
GILD: What are Zacks experts saying now?
Zacks Private Portfolio Services